Works matching IS 14642662 AND DT 2016 AND VI 17


Results: 116
    1

    Table of Contents.

    Published in:
    HIV Medicine, 2016, v. 17, n. 3, p. 161, doi. 10.1111/hiv.12328
    Publication type:
    Article
    2

    Editorial Board.

    Published in:
    HIV Medicine, 2016, v. 17, n. 3, p. 159, doi. 10.1111/hiv.12329
    Publication type:
    Article
    3
    4
    5

    Late presentation to HIV testing is overestimated when based on the consensus definition.

    Published in:
    HIV Medicine, 2016, v. 17, n. 3, p. 231, doi. 10.1111/hiv.12292
    By:
    • Sasse, A;
    • Florence, E;
    • Pharris, A;
    • De Wit, S;
    • Lacor, P;
    • Van Beckhoven, D;
    • Deblonde, J;
    • Delforge, M‐L;
    • Fransen, K;
    • Goffard, J‐C;
    • Legrand, J‐C;
    • Moutschen, M;
    • Piérard, D;
    • Ruelle, J;
    • Vaira, D;
    • Vandercam, B;
    • Van Ranst, M;
    • Van Wijngaerden, E;
    • Vandekerckhove, L;
    • Verhofstede, C
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Table of Contents.

    Published in:
    HIV Medicine, 2016, v. 17, n. 2, p. 79, doi. 10.1111/hiv.12326
    Publication type:
    Article
    19

    Editorial Board.

    Published in:
    HIV Medicine, 2016, v. 17, n. 2, p. 77, doi. 10.1111/hiv.12327
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Table of Contents.

    Published in:
    HIV Medicine, 2016, v. 17, n. 10, p. 711, doi. 10.1111/hiv.12342
    Publication type:
    Article
    30
    31

    Editorial Board.

    Published in:
    HIV Medicine, 2016, v. 17, n. 10, p. 709, doi. 10.1111/hiv.12343
    Publication type:
    Article
    32
    33
    34
    35
    36

    Psychiatric and substance use disorders in HIV/hepatitis C virus ( HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales ( ANRS) HEPAVIH CO13 cohort].

    Published in:
    HIV Medicine, 2016, v. 17, n. 10, p. 758, doi. 10.1111/hiv.12382
    By:
    • Michel, L;
    • Lions, C;
    • Winnock, M;
    • Lang, J‐P;
    • Loko, M‐A;
    • Rosenthal, E;
    • Marchou, B;
    • Valantin, M‐A;
    • Morlat, P;
    • Roux, P;
    • Sogni, P;
    • Spire, B;
    • Poizot‐Martin, I;
    • Lacombe, K;
    • Lascoux‐Combe, C;
    • Duvivier, C;
    • Neau, D;
    • Dabis, F;
    • Salmon‐Ceron, D;
    • Carrieri, MP
    Publication type:
    Article
    37
    38
    39

    Erratum.

    Published in:
    HIV Medicine, 2016, v. 17, n. 10, p. 781, doi. 10.1111/hiv.12439
    Publication type:
    Article
    40
    41
    42

    Issue Information.

    Published in:
    HIV Medicine, 2016, v. 17, p. 1, doi. 10.1111/hiv.12465
    Publication type:
    Article
    43

    Table of Contents.

    Published in:
    HIV Medicine, 2016, v. 17, n. 9, p. 637, doi. 10.1111/hiv.12340
    Publication type:
    Article
    44

    Editorial Board.

    Published in:
    HIV Medicine, 2016, v. 17, n. 9, p. 635, doi. 10.1111/hiv.12341
    Publication type:
    Article
    45
    46
    47

    Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy.

    Published in:
    HIV Medicine, 2016, v. 17, n. 9, p. 653, doi. 10.1111/hiv.12368
    By:
    • Estrada, V;
    • Monge, S;
    • Gómez‐Garre, MD;
    • Sobrino, P;
    • Masiá, M;
    • Berenguer, J;
    • Portilla, J;
    • Viladés, C;
    • Martínez, E;
    • Blanco, JR;
    • Moreno, Santiago;
    • Amo, Julia;
    • Dalmau, David;
    • Navarro, Maria Luisa;
    • González, Maria Isabel;
    • Garcia, Federico;
    • Rubio, Rafael;
    • Iribarren, Jose Antonio;
    • Gutiérrez, Félix;
    • Vidal, Francesc
    Publication type:
    Article
    48
    49
    50